Additionally, MET-amplified EGFR-TKI-resistant cells induce CD73, which is responsible for producing the immunosuppressive metabolite adenosine and inhibiting the activation of STING, potentially promoting tumor progression. This evidence concerns the gene EGFR and neoplasm.